Chemistry:3β-Methoxypregnenolone
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | Pregnenolone 3-methyl ether; 3β-Methoxypregn-5-en-20-one |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H34O2 |
| Molar mass | 330.512 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3β-Methoxypregnenolone (developmental code name MAP-4343), or pregnenolone 3β-methyl ether, also known as 3β-methoxypregn-5-en-20-one, is a synthetic neuroactive steroid and derivative of pregnenolone.[1][2][3][4] It interacts with microtubule-associated protein 2 (MAP2) in a similar manner to pregnenolone and is under development for potential clinical use for indications such as the treatment of brain and spinal cord injury and depressive disorders.[1][2][3][4]
See also
References
- ↑ 1.0 1.1 "Pregnenolone methyl ether - Mapreg - AdisInsight". http://adisinsight.springer.com/drugs/800034216.
- ↑ 2.0 2.1 "Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone". Brain Res. 1403: 57–66. 2011. doi:10.1016/j.brainres.2011.05.065. PMID 21704982.
- ↑ 3.0 3.1 "3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders". Proc. Natl. Acad. Sci. U.S.A. 109 (5): 1713–8. 2012. doi:10.1073/pnas.1121485109. PMID 22307636. Bibcode: 2012PNAS..109.1713B.
- ↑ 4.0 4.1 "From steroid hormones to depressive states and senile dementias: New mechanistic, therapeutical and predictive approaches". Comptes Rendus Biologies 338 (8–9): 613–6. 2015. doi:10.1016/j.crvi.2015.06.003. PMID 26251072.
 |  |
